Increasing Walking and Bright Light Exposure to Improve Sleep in Community-Dwelling Persons with Alzheimer's Disease: Results of a Randomized, Controlled Trial

被引:155
|
作者
McCurry, Susan M. [1 ]
Pike, Kenneth C. [1 ]
Vitiello, Michael V. [2 ]
Logsdon, Rebecca G. [1 ]
Larson, Eric B. [3 ]
Teri, Linda [1 ]
机构
[1] Univ Washington, Dept Psychosocial & Community Hlth, Seattle, WA 98115 USA
[2] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98115 USA
[3] Grp Hlth Res Inst, Seattle, WA USA
关键词
sleep; Alzheimer's disease; walking; light; adherence; NURSING-HOME RESIDENTS; PLACEBO-CONTROLLED TRIAL; INSTITUTIONALIZED PATIENTS; PHYSICAL-ACTIVITY; DEMENTIA; DISTURBANCES; PREDICTORS; MELATONIN; INSOMNIA; CAREGIVERS;
D O I
10.1111/j.1532-5415.2011.03519.x
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
OBJECTIVES: To test the effects of walking, light exposure, and a combination intervention (walking, light, and sleep education) on the sleep of persons with Alzheimer's disease (AD). DESIGN: Randomized, controlled trial with blinded assessors. SETTING: Independent community living. PARTICIPANTS: One hundred thirty-two people with AD and their in-home caregivers. INTERVENTIONS: Participants were randomly assigned to one of three active treatments (walking, light, combination treatment) or contact control and received three or six in-home visits. MEASUREMENTS: Primary outcomes were participant total wake time based on wrist actigraphy and caregiver ratings of participant sleep quality on the Sleep Disorders Inventory (SDI). Secondary sleep outcomes included additional actigraphic measurements of sleep percentage, number of awakenings, and total sleep time. RESULTS: Participants in walking (P = .05), light (P = .04), and combination treatment (P = .01) had significantly greater improvements in total wake time at posttest (effect size 0.51-0.63) than controls but no significant improvement on the SDI. Moderate effect size improvements in actigraphic sleep percentage were also observed in active treatment participants. There were no significant differences between the active treatment groups and no group differences for any sleep outcomes at 6 months. Participants with better adherence (4 d/wk) to walking and light exposure recommendations had significantly less total wake time (P = .006) and better sleep efficiency (P = .005) at posttest than those with poorer adherence. CONCLUSION: Walking, light exposure, and their combination are potentially effective treatments for improving sleep in community-dwelling persons with AD, but consistent adherence to treatment recommendations is required. J Am Geriatr Soc 59: 1393-1402, 2011.
引用
收藏
页码:1393 / 1402
页数:10
相关论文
共 50 条
  • [41] Exercise rehabilitation on home-dwelling patients with Alzheimer's disease - a randomized, controlled trial. Study protocol
    Pitkala, Kaisu H.
    Raivio, Minna M.
    Laakkonen, Marja-Liisa
    Tilvis, Reijo S.
    Kautiainen, Hannu
    Strandberg, Timo E.
    TRIALS, 2010, 11
  • [42] Effect of a financial incentive (shopping point) on increasing the number of daily walking steps among community-dwelling adults in Japan: a randomised controlled trial
    Tanji, Fumiya
    Tomata, Yasutake
    Abe, Saho
    Matsuyama, Sanae
    Kotaki, Yumika
    Nurrika, Dieta
    Matsumoto, Koichi
    Liu, Yingxu
    Zhang, Shu
    Lu, Yukai
    Sugawara, Yumi
    Bando, Shino
    Yamazaki, Teiichiro
    Otsuka, Tatsui
    Sone, Toshimasa
    Tsuji, Ichiro
    BMJ OPEN, 2020, 10 (11):
  • [43] Efficacy of Souvenaid in Mild Alzheimer's Disease: Results from a Randomized, Controlled Trial
    Scheltens, Philip
    Twisk, Jos W. R.
    Blesa, Rafael
    Scarpini, Elio
    von Arnim, Christine A. F.
    Bongers, Anke
    Harrison, John
    Swinkels, Sophie H. N.
    Stam, Cornelis J.
    de Waal, Hanneke
    Wurtman, Richard J.
    Wieggers, Rico L.
    Vellas, Bruno
    Kamphuis, Patrick J. G. H.
    JOURNAL OF ALZHEIMERS DISEASE, 2012, 31 (01) : 225 - 236
  • [44] Incidence of prescription vitamin B12 use in relation to diagnosis of Alzheimer’s disease among community-dwelling persons
    Satu Pölönen
    Miia Tiihonen
    Irma Nykänen
    Heidi Taipale
    Anna-Maija Tolppanen
    Sirpa Hartikainen
    Journal of Public Health, 2019, 27 : 775 - 779
  • [45] Predictors of decline in walking ability in community-dwelling Alzheimer's disease patients: Results from the 4-years prospective REAL.FR study
    Rolland, Yves
    Cantet, Christelle
    Barreto, Philipe de Souto
    Cesari, Matteo
    van Kan, Gabor Abellan
    Vellas, Bruno
    ALZHEIMERS RESEARCH & THERAPY, 2013, 5 (05):
  • [46] Risk of head and traumatic brain injuries associated with antidepressant use among community-dwelling persons with Alzheimer's disease: a nationwide matched cohort study
    Taipale, Heidi
    Koponen, Marjaana
    Tanskanen, Antti
    Lavikainen, Piia
    Sund, Reijo
    Tiihonen, Jari
    Hartikainen, Sirpa
    Tolppanen, Anna-Maija
    ALZHEIMERS RESEARCH & THERAPY, 2017, 9
  • [47] A 12-Week Physical and Cognitive Exercise Program Can Improve Cognitive Function and Neural Efficiency in Community-Dwelling Older Adults: A Randomized Controlled Trial
    Nishiguchi, Shu
    Yamada, Minoru
    Tanigawa, Takanori
    Sekiyama, Kaoru
    Kawagoe, Toshikazu
    Suzuki, Maki
    Yoshikawa, Sakiko
    Abe, Nobuhito
    Otsuka, Yuki
    Nakai, Ryusuke
    Aoyama, Tomoki
    Tsuboyama, Tadao
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2015, 63 (07) : 1355 - 1363
  • [48] Impact of an educational programme on Alzheimer's disease patients' quality of life: results of the randomized controlled trial THERAD
    Villars, Helene
    Cantet, Christelle
    de Peretti, Eva
    Perrin, Amelie
    Soto-martin, Maria
    Gardette, Virginie
    ALZHEIMERS RESEARCH & THERAPY, 2021, 13 (01)
  • [49] EFFICACY OF A MEDICAL FOOD ON COGNITION IN ALZHEIMER'S DISEASE: RESULTS FROM SECONDARY ANALYSES OF A RANDOMIZED, CONTROLLED TRIAL
    Kamphuis, P. J. G. H.
    Verhey, F. R. J.
    Rikkert, M. G. M. Olde
    Twisk, J. W. R.
    Swinkels, S. H. N.
    Scheltens, P.
    JOURNAL OF NUTRITION HEALTH & AGING, 2011, 15 (08) : 720 - 724
  • [50] A double-blind randomized controlled trial to assess the effect of bright light therapy on depression in patients with Parkinson's disease
    Rutten, Sonja
    Vriend, Chris
    Smit, Jan H.
    Berendse, Henk W.
    Hoogendoorn, Adriaan W.
    van den Heuvel, Odile A.
    van der Werf, Ysbrand D.
    BMC PSYCHIATRY, 2016, 16